Desprez Pierre-Yves, Sumida Tomoki, Coppé Jean-Philippe
California Pacific Medical Center, Cancer Research Institute, San Francisco, California 94115, USA.
J Mammary Gland Biol Neoplasia. 2003 Apr;8(2):225-39. doi: 10.1023/a:1025957025773.
The basic helix-loop-helix (bHLH) family of transcription factors functions in the coordinated regulation of gene expression, cell lineage commitment, and cell differentiation in most mammalian tissues. Helix-loop-helix Id (Inhibitor of DNA binding) proteins are distinct from bHLH transcription factors in that they lack the basic domain necessary for DNA binding. Id proteins thus function as dominant negative regulators of bHLH transcription factors. The inhibition of bHLH factor activity by forced constitutive expression of Id proteins is closely associated with the inhibition of differentiation in a number of different cell types, including mammary epithelial cells. Moreover, recent literature suggests important roles of HLH proteins in many normal and transformed tissues, including mammary gland. Therefore, future directions for prognosis or therapeutic treatments of breast cancer may be able to exploit bHLH and Id genes as useful molecular targets. The purpose of this review is to summarize the evidence implicating HLH proteins in the regulation of normal and transformed mammary epithelial cell phenotypes.
转录因子的基本螺旋-环-螺旋(bHLH)家族在大多数哺乳动物组织中的基因表达、细胞谱系定向和细胞分化的协调调控中发挥作用。螺旋-环-螺旋Id(DNA结合抑制因子)蛋白与bHLH转录因子不同,因为它们缺乏DNA结合所需的基本结构域。因此,Id蛋白作为bHLH转录因子的显性负调控因子发挥作用。通过强制组成型表达Id蛋白对bHLH因子活性的抑制与多种不同细胞类型(包括乳腺上皮细胞)的分化抑制密切相关。此外,最近的文献表明HLH蛋白在包括乳腺在内的许多正常和转化组织中具有重要作用。因此,乳腺癌预后或治疗的未来方向可能能够利用bHLH和Id基因作为有用的分子靶点。本综述的目的是总结涉及HLH蛋白在正常和转化乳腺上皮细胞表型调控中的证据。